Lafaine Grant, M.D., is an Associate Professor in the UT Southwestern Medical Center’s Department of Internal Medicine.

Dr. Grant earned her medical degree at Wake Forest University School of Medicine. She completed her residency in internal medicine at Emory University Hospital and a fellowship in gastroenterology at the Washington University School of Medicine. She then completed an advanced fellowship in hepatology at Baylor University Medical Center. She joined the staff of UT Southwestern in 2007.

Dr. Grant is a member of the American Medical Association, the American Gastroenterological Association, and the American Association for the Study of Liver Diseases.


Medical School
Wake Forest University School of Medicine (1997)
Emory University Hospital (2000), Internal Medicine
Washington University School of Medicine (2004), Gastroenterology
Research Fellowship
Baylor University Medical Center (2007), Hepatology

Research Interest

  • Gastroenterology
  • Hepatology


Featured Publications LegendFeatured Publications

More Than a Rash: Recurrent Hepatocellular Carcinoma After Liver Transplantation.
Moraveji S, Pedersen MR, Chandramouli S, Kerr TA, Grant LM, ACG Case Rep J 2019 Jul 6 7 e00107
Two-stage liver transplant for ruptured hepatic adenoma: A case report.
Salhanick M, MacConmara MP, Pedersen MR, Grant L, Hwang CS, Parekh JR, World J Hepatol 2019 Feb 11 2 242-249
Outcomes of simultaneous liver-kidney transplantation: implications for patient selection.
Grant L, Tujios S, Singal AG Curr Opin Organ Transplant 2018 Jan
Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network.
Navarro VJ, Barnhart H, Bonkovsky HL, Davern T, Fontana RJ, Grant L, Reddy KR, Seeff LB, Serrano J, Sherker AH, Stolz A, Talwalkar J, Vega M, Vuppalanchi R, Hepatology 2014 Oct 60 4 1399-408
Clinical and Histological Features of Idiosyncratic Acute Liver Injury Caused by Temozolomide.
Grant LM, Kleiner DE, Conjeevaram HS, Vuppalanchi R, Lee WM Dig. Dis. Sci. 2012 Dec
Drug-induced liver injury.
Grant LM, Rockey DC Curr. Opin. Gastroenterol. 2012 May 28 3 198-202
Gastric bypass surgery improves metabolic and hepatic abnormalities associated with nonalcoholic fatty liver disease.
Klein S, Mittendorfer B, Eagon JC, Patterson B, Grant L, Feirt N, Seki E, Brenner D, Korenblat K, McCrea J Gastroenterology 2006 May 130 6 1564-72
Nonalcoholic fatty liver disease.
Grant LM, Lisker-Melman M Ann Hepatol 2004 Jul-Sep 3 3 93-9
Treatment of Hepatitis C Virus in the Liver Transplant Recipient.
Grant L, Crippin JS Curr Treat Options Gastroenterol 2003 Dec 6 6 517-522

Professional Associations/Affiliations

  • American College of Gastroenterology (2020)
  • American Association For The Study of Liver Diseases (2007)
  • American Gastroenterological Association
  • American Medical Association